that the remark by Grendar et al is deceptive. First, the difference is artificial (when not knowing the true values). Second, and more importantly, in practice one can easily adapt decision thresholds to these differences. For NIPT this would result in shifting the decision threshold with 2.5% between the two methods when deciding on having enough fetal DNA to reliably interpret NIPT results. Taken together; the claims we made are supported by the correlations; systematic biases are present as Grendar et al rightly pointed out, but they cannot be interpreted and can easily be accounted for in clinical practice; the accuracy of the estimates of the fetal fraction is not known due to lack of a gold standard, but for clinical practice this is not essential.
In a recent edition of Prenatal Diagnosis, we published a comparison between bioinformatic methods that estimate the fetal cell-free DNA fraction in maternal plasma, which is essential knowledge when performing NIPT tests. 1 Grendar et al confirmed the need for this paper, but commented on our findings by stating that we left data unexplored, mainly pointing towards observable biases between the different approaches (ie, deviation from the 45 o line through the origin in pairwise comparisons). 2 Clearly, these systematic differences can be observed (an updated figure showing this effect more clearly, as well as a table containing the underlying data are included as new supplementary data). However, since there is no gold standard available (ie, the true fetal fraction is unknown), nor is it (easily) faithfully extractable, it is not possible to confirm which bias is to be preferred. (Figure 1 in our manuscript) . As stated before, in the absence of a gold standard, there is no way to tell which one is better, which prompted us to the more general conclusion on using any Y-based method. Grendar et al, claim that these systematic differences (on the order of 2.5%) make a huge difference when used in the NIPT procedure. Granted, if we would have implied that the estimates are unbiased estimates of the real fractions, this
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FIGURE 1
The lower left part of the matrix shows our comparison of the 6 different methods to predict fetal fraction from single-read NGS data for 654 maternal blood plasma samples. Blue dots represent the male pregnancies; red dots, the female pregnancies. Gray and green dots represent male and female pregnancies of a failed run, which contained degraded fetal DNA. On the diagonal of the matrix, the correlations to BMI (B), weight (W), and the gestational age (G) are shown, respectively. A diagonal line has been included in all lower left panels to indicate systematic differences. The upper right part of the matrix shows the correlation between the 2 methods [Colour figure can be viewed at wileyonlinelibrary.com]
